| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.16 | 0.4 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.13 | 0.4 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.063 | 0.4 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |